Twist Bioscience and the Australian Research Council Centre of Excellence in Synthetic Biology (CoESB) announced a partnership that will enable CoESB members and partners to order a wide range of Twist products that facilitate research and development. Australia's commitment to the growing market of synthetic biology is made clear by the long-term funding commitment from the ARC in synthetic biology.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.21 USD | +28.74% | +30.66% | +11.80% |
May. 03 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
May. 03 | Sector Update: Health Care Stocks Mixed in Afternoon Trading | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.80% | 2.4B | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-14.38% | 12.07B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
+4.87% | 8.81B | |
-4.33% | 8.5B |
- Stock Market
- Equities
- TWST Stock
- News Twist Bioscience Corporation
- The Australian Research Council Centre of Excellence in Synthetic Biology and Twist Bioscience Partner to Foster and Accelerate Synthetic Biology Research in Australia